BridgeMD
Compares treatment options for Temporomandibular Disorder
Official title K23- Physical Self Regulation vs Placebo
ClinicalTrials.gov ID: NCT06357702
What this study is testing
- What it's testing
- This study will use a between-person design. Participants will be treatment-seeking patients with chronic masticatory muscle pain.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Have a primary or secondary chronic masticatory muscle pain diagnosis
- Provide signed and dated electronic informed consent form
- Willing to comply with all study procedures
- Male or female, aged 18 or over
- Be able to speak and write in English
You likely can't join if
- Currently using anticonvulsant, steroid, antispasmodic, or opioid medication for chronic pain 2 days a week or more often
- Have current or recent (within the last 3 months) psychotic, suicidal, homicidal, or manic symptoms. Participants with a history of such symptoms...
- Patients who are currently on medication for diabetes or seizures (i.e., epilepsy) must have written clearance from their medical providers prior to...
- History of seizures within the last 12 months
- Pain duration less than 3 months
- Pregnant or planning to become pregnant
See the full eligibility criteria
- Have a primary or secondary chronic masticatory muscle pain diagnosis
- Provide signed and dated electronic informed consent form
- Willing to comply with all study procedures
- Male or female, aged 18 or over
- Be able to speak and write in English
- Be seeking treatment at UKOPC
- Have the ability to perform telehealth visits (i.e., internet access, phone, tablet, computer or other device with audio/visual capabilities)
- Currently using anticonvulsant, steroid, antispasmodic, or opioid medication for chronic pain 2 days a week or more often
- Have current or recent (within the last 3 months) psychotic, suicidal, homicidal, or manic symptoms. Participants with a history of such symptoms must demonstrate psychiatric stability for at least 6 months and be under...
- Patients who are currently on medication for diabetes or seizures (i.e., epilepsy) must have written clearance from their medical providers prior to participating in the study
- History of seizures within the last 12 months
- Pain duration less than 3 months
- Pregnant or planning to become pregnant
The study team makes the final eligibility decision.
Where it's taking place
- Lexington, Kentucky, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lexington, Kentucky, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.